Mind your "Q"s: QPharma acquires Qforma
Combination expands breadth of commercialization and compliance services
Two New Jersey-based companies, both with expertise in life sciences commercial services, will now be known only as QPharma. Qforma, until now owned by a private investment firm, BelHealth Investment Partners, has developed analytics technology for “understanding and penetration” of professional relationship networks among healthcare providers and their affiliations, as well as a launch planning tool, iLaunch.
For 21 years, QPharma has provided a range of IT-based services, including systems validation, sample distribution management, state and federal transparency reporting and salesforce training. More recently, it has moved into key opinion-leader (KOL) identification, influence mapping and analytics.
“The purchase of Qforma is a natural progression of the incremental growth strategy that has served QPharma well in the past two decades,” said QPharma president and CEO, Patrick Den Boer, in a statement. “The outstanding technology platform and solution base they have built is a perfect complement to QPharma’s suite of business intelligence tools.”
Purchase price was not disclosed. QPharma says that its national headcount will get a 10% bump-up, but didn't release a total employment figure.
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches
October 24th 2024How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
